Indian Army Pharmaceutical and Diagnostic Supply Procurement

Work Description - NA

This tender, designated as GEM/2026/B/7887754 and dated 19-08-2026, is issued by the Department of Military Affairs, under the Ministry of Defence, for the Indian Army, with operations based in Pune City. The bid will commence on 19-08-2026 at 12:29 PM and conclude on 29-08-2026 at 1:00 PM. The procurement encompasses a comprehensive range of pharmaceutical products, including but not limited to Clomipramine HCl 25 mg, Clonazepam 0.25 mg, Etizolam 0.5 mg, Fluvoxamine 100 mg, Lorazepam 2 mg, Lithium Carbonate 300 mg, Mirtazapine 7.5 mg, Memantine 5 mg, Naltrexone 50 mg, Paroxetine 25 mg, Promethazine HCl 25 mg, Quetiapine (25 mg, 50 mg, and 200 mg), Risperidone (0.5 mg tablets and a 50 mg/2ml inj. for prolonged release), Topiramate 100 mg, Trazodone 50 mg, Venlafaxine 37.5 mg, Risperidone Consta 25 mg Injection, and Clobazam 5 mg. Additionally, the tender includes Endoxifen 8 mg tablets, Tizanidine 2 mg tablets, and a Multi Drug One Step Multi-line Screen Test Device for urine. The total quantity required across all items is 101,630 units.